Direkt zum Inhalt
Merck

Y0001969

Etanercept

European Pharmacopoeia (EP) Reference Standard

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

CAS-Nummer:
UNSPSC-Code:
41116107
NACRES:
NA.24
Preise und Verfügbarkeit sind derzeit nicht verfügbar.

Qualität

pharmaceutical primary standard

API-Familie

etanercept

Hersteller/Markenname

EDQM

Anwendung(en)

pharmaceutical

Format

neat

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

Etanercept is one of the biologic disease-modifying anti-rheumatic drugs (DMARDs) used to treat rheumatoid arthritis (RA). It acts as a tumor necrosis factor (TNF) antagonist by binding with TNF cytokine or protein, thereby blocking its interaction with cell surface receptors. Thus, etanercept effectively relieves joint inflammation from RA and lowers the disease activity.[1][2][3][4][5][6]
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

This product is intended for laboratory tests as prescribed in the EP only. Established for use with the monograph(s): 2895.

Verpackung

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Development of a sensitive enzyme-linked immunosorbent assay for the measurement of biologically active etanercept in patients with ankylosing spondylitis
Wang L, et al.
Journal of Chromatography. B, Biomedical Applications, 1008, 219-224 (2016)
Etanercept concentration in patients with rheumatoid arthritis and its potential influence on treatment decisions: a pilot study
Daien CI, et al.
The Journal of Rheumatology, 39(8), 1533-1538 (2012)
Characterization and application of a unique panel of monoclonal antibodies generated against etanercept
Detrez I, et al.
Journal of Immunology, 196(6), 2879-2884 (2016)
Etanercept
European Pharmacopoeia Commission and Directorate for the Quality of Medicines & Healthcare
European pharmacopoeia, 4979-4983 (2021)
Etanercept: An overview
Goffe B and Cather JC
Journal of the American Academy of Dermatology, 49(2), 105-111 (2003)

Fragen

1-2 von 2 Fragen  
  1. Bonjour, j'ai reconstitué un aliquot d'étanercept dans l'eau. combien de temps puis je le garder à 4 degres ou est il preferable de le congeler?

    1 Antwort
    1. Recommendations against the long-term storage and use of this standard are listed in the associated Information Leaflet published by the European Pharmacopoeia. From the leaflet:

      "The container should not be opened until required for use. Allow the closed container to equilibrate at ambient temperature before opening to avoid uptake of moisture. This substance has been freeze-dried and is known to be hygroscopic. Tap the container gently to collect the material at the bottom. Reconstitute the contents by injecting a suitable volume of the solvent. Mix gently to ensure complete dissolution. When necessary transfer the solution to an appropriate volumetric flask and dilute to the required concentration. Ph. Eur. RS are for immediate use. Once the container has been opened, its entire content must be used immediately. Any further storage and re-use are not warranted."

      Hilfreich?

  2. What is the recommended method for reconstituting Etanercept (Y0001969), and how should the stock solutions be stored?

    1 Antwort
    1. Etanercept (Y0001969) is soluble in water. Once reconstituted, stock solutions should be aliquoted into tightly sealed vials and used within one month to ensure stability. It is important to avoid repeated freeze-thaw cycles to maintain the integrity of the solution.

      Hilfreich?

Bewertungen

Kein Beurteilungswert

Aktive Filter

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.